As the Chinese healthcare market grows by double digits annually, the demands for true knowledge about the Chinese patient population, the standards of care in China and the market size of different therapeutic areas have increased rapidly.

Draco creates value to our clients' business through our specialization in the Chinese healthcare system. Draco has focused on the following key areas that are important for pharmaceutical companies:

• China epidemiology data
• Annual sales data on prescription drugs in key therapeutic areas in China
• Cancer treatment architectures in China
• Primary market researches with Chinese healthcare experts, including hospital administrators, practicing physicians and key opinion leaders (KOLs)
• Forecasting

The access to care situation in China has improved significantly with the on-going healthcare reform in China.  As a leader in the China-focused healthcare consulting business, Draco strongly believes that the greater China region should be an essential component of pharmaceutical companies' growth strategies.

• Draco has on-the-ground knowledge about China's epidemiology data and has many years of experience in developing Chinese epidemiology data with the highest quality possible
• Draco’ annually sales data on Chinese prescription drugs cover most key therapeutic areas in China, including cancer, diabetes, hypertension and other 19 disease areas; the data source is directly from the top medicine economics institute with 15% of Chinese hospitals sampled
• Draco’s multi-client reports on cancer treatment architectures in China provide expertise guidance on how cancers are treated in China, including treatment modalities, lines of chemotherapies as well as details about cancer regimens choice and utilization cycles, etc. Draco has interviewed thousands of Chinese physicians specializing in cancer treatments from major Level III hospitals where most of the Chinese cancer patients are treated
• Draco has provided services to many world leading pharmaceutical companies, biotech companies and healthcare consultancies
• Our local Chinese partners have solid relationships with Chinese hospital providers, physician panels and industry leaders

Working together with you, Draco's team is committed to help you answer your questions about the China's healthcare market.

Enabling our clients in the China's healthcare market is Draco's business

• 2nd China Forecasting Workshop, San Francisco, USA, June 2012
• China Forecasting Workshop, Philadelphia, USA, 2011
• China Pharmaceutical and Epidemiology Workshop, Japan, July 2011
• China Pharmaceutical and Epidemiology Workshop, 2010
• China Pharmaceutical Workshop (Healthcare Market and Epidemiology) in Tokyo, Japan March, 2010
• China Epidemiology Workshop in Beijing, China. October 2009